Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study.
Crit Care. 2011 Jan 28;15(1):R42
Authors: Wang F, Pan W, Pan S, Wang S, Ge Q, Ge J
ABSTRACT: INTRODUCTION: The performance of N-terminal pro-brain natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) to predict clinical outcomes in ICU patients is unimpressive. We aimed to assess the prognostic value of NT-proBNP, CRP or the combination of both in unselected medical ICU patients. METHODS: A total of 576 consecutive patients were screened for eligibility and followed up during the ICU stay. We collected each patient's baseline characteristics including the Acute Physiology and Chronic Health Evaluation II (APACHE-II) score, NT-proBNP and CRP levels. The primary outcome was ICU mortality. Potential predictors were analyzed for possible association with outcomes. We also evaluated the ability of NT-proBNP and CRP additive to APACHE-II score to predict ICU mortality by calculation of C-index, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices. RESULTS: Multiple regression revealed that CRP, NT-proBNP, APACHE-II score and fasting plasma glucose independently predicted ICU mortality (all P<0.01). The C-index with respect to prediction of ICU mortality of APACHE II score (0.82+/-0.02; P<0.01) was greater than that of NT-proBNP (0.71+/-0.03; P<0.01) or CRP (0.65+/-0.03; P<0.01) (all P<0.01). As compared with APACHE-II score (0.82+/-0.02; P<0.01), combination of CRP (0.83+/-0.02; P<0.01) or NT-proBNP(0.83+/-0.02; P<0.01) or both (0.84+/-0.02; P<0.01) with APACHE-II score did not significantly increase C-index for predicting ICU mortality (all P>0.05). However, addition of NT-proBNP to APACHE-II score gave IDI of 6.6% (P=0.003) and NRI of 16.6 % (P=0.007), addition of CRP to APACHE-II score provided IDI of 5.6% (P=0.026) and NRI of 12.1% (P=0.023), and addition of both markers to APACHE-II score yielded IDI of 7.5% (P=0.002) and NRI of 17.9 % (P=0.002). In the cardiac subgroup (N=213), NT-proBNP but not CRP independently predicted ICU mortality and addition of NT-proBNP to APACHE-II score obviously increased predictive ability (IDI=10.2%, P=0.018; NRI=18.5%, P=0.028). In the non-cardiac group (N=363), CRP rather than NT-proBNP was an independent predictor of ICU mortality. CONCLUSIONS: In unselected medical ICU patients, NT-proBNP and CRP can serve as independent predictors of ICU mortality and addition of NT-proBNP or CRP or both to APACHE-II score significantly improves the ability to predict ICU mortality. NT-proBNP appears to be useful for predicting ICU outcomes in cardiac patients.
PMID: 21272380 [PubMed - as supplied by publisher]